80% recurring annual revenue, 20% of revenue can be impacted by coronavirus, and they are sitting on enough cash to meet their $20m/year debt obligations. This news is probably as good as we can get in these circumstances?
- Forums
- ASX - By Stock
- LNK
- Ann: COVID-19 pandemic,market volatility & withdrawal of guidance
Ann: COVID-19 pandemic,market volatility & withdrawal of guidance, page-3
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LNK (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online